Google
Trusted Resources: News & Events
Latest announcements and gatherings
DDCF Awards $6 Million for Sickle Cell Disease Research
The Doris Duke Charitable Foundation has announced grants totaling $6 million in support of seven research projects addressing the causes of sickle cell disease.
Sickle cell disease, the most common inherited blood disorder in the United States, affects approximately a hundred thousand Americans. Patients with sickle cell disease carry dysfunctional red blood cells that alter regular blood flow, which translates into pain, poor organ oxygenation and organ damage, and a life span of only about forty years.
The first grants awarded through DDCF’s Sickle Cell Disease/Advancing Cures awards competition will support projects designed to develop disease-modifying approaches to sickle cell disease and translate them into clinically feasible therapies. By restoring hemoglobin function, researchers aim to remove patients’ need to manage the disease’s acute, devastating, and lifelong symptoms, ultimately increasing their life expectancy.
+myBinderRelated Content
-
Factors influencing utilization of hospital services by adult sickle cell disease patients: a systematic reviewBACKGROUND: Painful vaso-occlusive crisi...
-
Columbia University Medical CenterThe Division of Pediatric Hematology at ...
-
Doris Duke Charitable Foundation awards grant to Critical Path InstituteIn a continuing effort to spur advance...
-
Today’s Faces of Sickle Cell Disease: Tosin OlaDuring a long hospitalization in 2005, T...
-
Perceptions of US Adolescents and Adults With Sickle Cell Disease on Their Quality of CareImportance: Sickle cell disease (SCD) i...
-
Nadine Matthie, PhD, RNNadine Matthie is an assistant professor...
-
Carla JonesAnyone affected by sickle cell disease k...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.